Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients

Application of a BRAF V600E Mutation-specific Antibody for the Diagnosis of Hairy Cell Leukemia

(2012) Mindaugas Andrulis et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma

(2012) Oskar Koperek et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations

(2012) Xiang-Hua Zhang et al.   CANCER LETTERS

Pitfalls in Lung Cancer Molecular Pathology: How to Limit them in Routine Practice?

(2012) M. Ilie et al.   CURRENT MEDICINAL CHEMISTRY

KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics

(2012) Daniëlle A.M. Heideman et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma

(2012) Adnan Hasanovic et al.   LUNG CANCER

Role of molecular studies in the diagnosis of lung adenocarcinoma

(2012) Samuel A Yousem   MODERN PATHOLOGY

Molecular pathology of lung cancer: key to personalized medicine

(2012) Liang Cheng et al.   MODERN PATHOLOGY

CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity

(2012) J. James et al.   MOLECULAR CANCER THERAPEUTICS

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

(2011) David Capper et al.   ACTA NEUROPATHOLOGICA

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

(2011) David Capper et al.   ACTA NEUROPATHOLOGICA

Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma

(2011) P. Hofman et al.   ANNALS OF ONCOLOGY

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

(2011) T Yokota et al.   BRITISH JOURNAL OF CANCER

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations

(2011) Antonio Marchetti et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Characteristics of Patients With Lung Adenocarcinomas HarboringBRAFMutations

(2011) Paul K. Paik et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel Therapeutic Targets in Non-small Cell Lung Cancer

(2011) Filip Janku et al.   Journal of Thoracic Oncology

Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study

(2011) Anne McLeer-Florin et al.   Journal of Thoracic Oncology

Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma-Rationale for Comprehensive Mutation Profiling

(2011) J. E. Chaft et al.   MOLECULAR CANCER THERAPEUTICS

Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer

(2010) A. Kitamura et al.   CLINICAL CANCER RESEARCH

Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma

(2010) Marius I. Ilie et al.   VIRCHOWS ARCHIV

Micropapillary Lung Adenocarcinoma

(2009) Rosane De Oliveira Duarte Achcar et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Sorafenib Inhibits Non-Small Cell Lung Cancer Cell Growth by Targeting B-RAF in KRAS Wild-Type Cells and C-RAF in KRAS Mutant Cells

(2009) K. Takezawa et al.   CANCER RESEARCH

KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial

(2009) Susan D. Richman et al.   JOURNAL OF CLINICAL ONCOLOGY

The Histopathology of BRAF-V600E–mutated Lung Adenocarcinoma

(2008) Samuel A. Yousem et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Genetic Predictors of MEK Dependence in Non-Small Cell Lung Cancer

(2008) C. A. Pratilas et al.   CANCER RESEARCH

Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma

(2008) G. J. Riely et al.   CLINICAL CANCER RESEARCH

Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma

(2008) Kazunori Kamiya et al.   MODERN PATHOLOGY